Track topics on Twitter Track topics that are important to you
Synlogic (NASDAQ: SYBX) has appointed Scott Plevy to serve as chief scientific officer. A gastroenterologist, Plevy was most recently a vice president in gastroenterology disease at Janssen Research & Development. Cambridge, MA-based Synlogic is developing drugs that employ engineered microbes to treat metabolic and inflammatory diseases, as well as cancer.
Original Article: Janssen’s Scott Plevy Joins Synlogic as Chief Scientific OfficerNEXT ARTICLE
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...